Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
AIDS (London, England)|November 13, 2015
Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b)Adriana Andrade, Jeremie Guedj, Susan L Rosenkranz, et al.
AIDS (London, England)|March 4, 2006
Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108Judith A Aberg, Susan L Rosenkranz, Carl J Fichtenbaum, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Phase I Study To Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult ParticipantsEric Wenzler, Susan C Bleasdale, Monica Sikka, et al.
AIDS (London, England)|September 7, 2006
The impact of sex and contraceptive therapy on the plasma and intracellular pharmacokinetics of zidovudineFrancesca T Aweeka, Susan L Rosenkranz, Yoninah Segal, et al.
Archives of Oral Biology|June 29, 2026
Development of models of preclinical stage 2 bisphosphonate-related osteonecrosis of the jaw in non-rodent mammals using zoledronate: A systematic reviewPrasiddha Mahardhika El Fadhlallah, Meircurius Dwi Condro Surboyo, Alex Kesuma, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistanceHulin Wu, Yangxin Huang, Edward P Acosta, et al.
Bioanalysis|November 22, 2014
Adding value to antiretroviral proficiency testingRobin DiFrancesco, Charlene R Taylor, Susan L Rosenkranz, et al.
AIDS Research and Human Retroviruses|January 11, 2008
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patientsRahul P Bakshi, Fayez Hamzeh, Ian Frank, et al.
AIDS (London, England)|March 2, 2002
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047Carl J Fichtenbaum, John G Gerber, Susan L Rosenkranz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 28, 2015
Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE studyAnne F Luetkemeyer, Susan L Rosenkranz, Darlene Lu, et al.
Pageof 7